Neon therapeutics, inc. (NTGN)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Dec'17
Assets
Current assets:
Cash and cash equivalents

15,047

29,395

44,278

46,285

49,264

52,700

60,779

130,804

58,250

Debt Securities, Available-for-sale

-

-

0

14,714

-

-

-

-

-

Marketable securities

-

-

-

-

32,000

50,611

60,962

7,829

21,475

Prepaid expenses and other current assets

1,962

1,848

2,036

1,998

2,349

2,116

2,269

1,559

1,581

Total current assets

17,009

31,243

46,314

62,997

83,613

105,427

124,010

140,192

81,306

Operating lease, right-of-use assets

7,228

7,542

7,848

8,148

8,441

-

-

-

-

Property, Plant and Equipment, Net

6,694

7,109

7,670

8,046

8,488

8,205

7,962

7,614

6,888

Deferred offering costs

-

-

-

-

-

-

-

-

1,567

Other long-term assets

471

478

485

491

498

456

607

607

732

Total assets

31,402

46,372

62,317

79,682

101,040

114,088

132,579

148,413

90,493

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable

3,043

1,702

1,935

2,751

4,112

4,268

2,742

1,168

2,166

Accrued Liabilities, Current

6,437

7,464

6,968

6,371

6,237

8,422

6,809

7,962

6,601

Operating lease liabilities, current

1,287

1,241

1,196

1,153

1,110

-

-

-

-

Total current liabilities

10,767

10,407

10,099

10,275

11,459

12,690

9,551

9,130

8,767

Operating lease liabilities, net of current portion

6,200

6,542

6,875

7,185

7,488

-

-

-

-

Other liabilities

4

6

9

16

22

149

121

35

48

Total liabilities

16,971

16,955

16,983

17,476

18,969

12,839

9,672

9,165

8,815

Commitments and contingencies (Note 8)

-

-

-

-

-

-

0

0

-

Temporary Equity, Carrying Amount, Attributable to Parent

-

-

-

-

-

-

-

-

175,250

Stockholders’ equity:
Common stock, $0.001 par value; 150,000,000 shares authorized as of March 31, 2020 and December 31, 2019; 28,963,858 and 28,729,725 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

29

29

28

28

28

28

28

28

3

Additional paid-in capital

284,538

282,926

281,004

278,896

276,837

275,058

273,542

271,470

0

Accumulated other comprehensive loss

-

-

0

0

-8

-75

-24

-2

-13

Retained Earnings (Accumulated Deficit)

-270,100

-253,538

-235,698

-216,718

-194,786

-173,762

-150,639

-132,248

-93,600

Stockholders' Equity Attributable to Parent

14,431

29,417

45,334

62,206

82,071

101,249

122,907

139,248

-93,572

Total liabilities and stockholders’ equity

31,402

46,372

62,317

79,682

101,040

114,088

132,579

148,413

90,493

Redeemable convertible preferred stock (Series A and B)
Temporary Equity, Carrying Amount, Attributable to Parent

-

-

-

-

-

-

-

-

174,895

Contingently redeemable restricted common stock
Temporary Equity, Carrying Amount, Attributable to Parent

-

-

-

-

-

-

-

-

355